60 composite-residual-stress-development Postdoctoral positions at University of Minnesota
Sort by
Refine Your Search
-
Previous Job Job Title Post-Doctoral Associate - Department of Ecology, Evolution and Behavior Next Job Apply for Job Job ID 368742 Location Twin Cities Job Family Academic Full/Part Time Full-Time
-
composition, food intake and preference measurements, and cognitive and anxiety/addiction potency testing. • Inject various compounds and solutions into experimental animals. • Assist with and eventually
-
by child welfare. The postdoc would receive training in community based participatory research processes as well as parent intervention development and evaluation. This is a part time position at 15
-
, Professor). Our research focuses on stress psychobiology, addiction, and global health research. The candidate will have access to a rich clinical research environment within the NIH funded CTSI and other
-
is limited to a period of up to three to five years, depending on training needs and funding available. The University of Minnesota encourages a healthy work life balance for employees. CEHD is
-
on applying, developing and implementing novel statistical and computational methods for integrative data analysis, causal inference, and machine/deep learning with GWAS/sequencing data and other types of omic
-
discussions around sensemaking of mathematics in biology and chemistry Developing and conducting and coding interviews of instructors teaching and/or students learning mathematical expressions in biology
-
) and developing meaningful scaled score formulas and metrics. The post-doctoral associate will support multiple aspects of this work, including conceptualization and design of the scale scores, computing
-
of Minnesota is seeking a highly motivated Postdoctoral Researcher to join a dynamic team focused on developing intelligent neurotechnologies for translational medicine. The lab specializes in computational
-
. However, limited availability of peritoneal dialysate has limited the impact of past attempts to introduce PD as a treatment modality. The technology being developed in our lab is a biopharmaceutical device